The present invention relates to Pyrazolopyrimidine Analogs, methods of
making Pyrazolopyrimidine Analogs, compositions comprising a
Pyrazolopyrimidine Analog, and methods for treating mTOR-related
disorders comprising administering to a subject in need thereof an
effective amount of a Pyrazolopyrimidine Analog. The invention also
relates to treating PI3K-related disorders comprising administering to a
subject in need thereof an effective amount of a Pyrazolopyrimidine
Analog.